Ticker Details
XOMA Corporation XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics.
IPO Date:	July 1, 1986
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$438.02M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 3.10%
Avg Daily Range (30 D):	$0.59 | 2.03%
Avg Daily Range (90 D):	$0.71 | 2.58%

Institutional Daily Volume
Avg Daily Volume:	.89M
Avg Daily Volume (30 D):	.1M
Avg Daily Volume (90 D):	.28M

Trade Size
Avg Trade Size (Sh.):	384
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	90

Institutional Trades
Total Institutional Trades:	401
Avg Institutional Trade:	$1.64M
Avg Institutional Trade (30 D):	$1.03M
Avg Institutional Trade (90 D):	$1.03M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.42M
Avg Closing Trade (30 D):	$1.03M
Avg Closing Trade (90 D):	$1.03M
Avg Closing Volume:	70.6K

News

Mar 18, 2026 @ 8:30 PM XOMA Royalty Declares Quarterly Preferred Stock Di... Source: Globe Newswire

Mar 18, 2026 @ 10:00 AM XOMA Royalty Reports 2025 Financial Results and Hi... Source: Na

Feb 9, 2026 @ 2:53 PM XOMA Royalty Announces Closing of Tender Offer and... Source: Globe Newswire

Jan 20, 2026 @ 9:47 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 22, 2025 @ 12:30 PM XOMA Royalty Declares Quarterly Preferred Stock Di... Source: Globe Newswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$1.53	$.27	$1.53
Diluted EPS	$1.46	$.26	$1.46
Revenue	$52.15M	$13.76M	$52.15M
Gross Profit
Net Income / Loss	$31.71M	$6.1M	$31.71M
Operating Income / Loss	$11.38M	$2.18M	$11.38M
Cost of Revenue
Net Cash Flow	$27.29M	$3.16M	$27.29M
PE Ratio	25.16

Splits
Oct 18, 2016	1:20
Aug 18, 2010	1:15